Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

Saved in:
Bibliographic Details
Published in:European urology 2024-03, Vol.85, p.S62-S63
Main Authors: Giesen, A., Devos, G., Tosco, L., Baekelandt, L., Baldewijns, M., Gevaert, T., Goffin, K., Petit, V., Mai, C., Raskin, Y., Van Haute, C., Goeman, L., De Meerleer, G., Berghen, C., Devlies, W., Claessens, F., Van Poppel, H., Everaerts, W., Joniau, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(24)00130-1